| Author (Corporate) | European Monitoring Centre for Drugs and Drug Addiction |
|---|---|
| Publisher | EU |
| Publication Date | 06/06/2017 |
| Content Type | Report, Statistics |
|
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions were explored in EMCDDA's annual overview of the European drug situation European Drug Report 2017 published on the 6 June 2017. The European Drug Report 2017: Trends and Developments, provides a comprehensive analysis of the latest tendencies across the 28 EU Member States, Turkey and Norway. The report examines: drug supply and the market; drug use prevalence and trends; and drug-related harms and responses to them. Accompanying the report was the 2017 Statistical Bulletin, containing the European dataset underpinning the analysis. The report was complemented for the first time by 30 Country Drug Reports, presenting summaries of national drug phenomena (EU 28, Turkey and Norway). Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply. |
|
| Source Link | Link to Main Source http://www.emcdda.europa.eu/edr2017 |
| Related Links |
|
| Subject Categories | Health |
| Countries / Regions | Europe |
